In this randomised , placebo-controlled , double-blind , proof-of-concept phase 1 study , we enrolled healthy volunteers ( aged 18-45 years ) with a body-mass index of 185-299 kg/m ( 2 ) into one of four dose groups at SGS Life Sciences Clinical Research Services , Belgium .